Save your place

Sign in to WhoBought

Please try again later.

Atea Pharmaceuticals, Inc. (AVIR) institutional ownership

Latest close $4.73 Jul 24, 2026
Market cap$297M 52-week range SectorHealthcare
Funds holding · Q1 2026
108
reported AVIR position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
60 buyers · 48 sellers

Atea Pharmaceuticals, Inc. (AVIR) price and institutional activity

Dates

Q1 2026

$0 bought by 60 investors
FMR LLCRosalind Advisors, Inc. +58 more
$0 sold by 48 investors
Two Sigma Advisers, LPBml Capital Management, LLC +46 more
Bought Sold Totals per quarter; hover a bar for the names.

Atea Pharmaceuticals, Inc. (AVIR) institutional activity · 108

Investor Type Est. change Change Δ Own Date
FMR LLC · Added
Change +2.3M Δ Own +23.5% Date Q1 2026
FMR LLC Added· Q1 2026 +2.3M +23.5% Q1 2026
Rosalind Advisors, Inc. · New
Change +1.2M Date Q1 2026
Rosalind Advisors, Inc. New· Q1 2026 +1.2M Q1 2026
Two Sigma Investments, LP · Added
Change +1.1M Δ Own +150.1% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +1.1M +150.1% Q1 2026
Two Sigma Advisers, LP · Exited
Change −1.1M Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −1.1M −100.0% Q1 2026
Bml Capital Management, LLC · Reduced
Change −431K Date Q1 2026
Bml Capital Management, LLC Reduced· Q1 2026 −431K Q1 2026
JPMorgan Chase & Co · Reduced
Change −408K Date Q1 2026
JPMorgan Chase & Co Reduced· Q1 2026 −408K Q1 2026
Millennium Management LLC · Reduced
Change −348K Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −348K Q1 2026
Irenic Capital Management LP · New
Change +302K Date Q1 2026
Irenic Capital Management LP New· Q1 2026 +302K Q1 2026
Acadian Asset Management LLC · Added
Change +279K Date Q1 2026
Acadian Asset Management LLC Added· Q1 2026 +279K Q1 2026
Arrowstreet Capital, Limited Partnership · New
Change +211K Date Q1 2026
Arrowstreet Capital, Limited Partnership New· Q1 2026 +211K Q1 2026
Wellington Management Group LLP · Reduced
Change −186K Δ Own −76.5% Date Q1 2026
Wellington Management Group LLP Reduced· Q1 2026 −186K −76.5% Q1 2026
Jane Street Group, LLC · Added
Change +168K Date Q1 2026
Jane Street Group, LLC Added· Q1 2026 +168K Q1 2026
Peapod Lane Capital LLC · Reduced
Change −162K Date Q1 2026
Peapod Lane Capital LLC Reduced· Q1 2026 −162K Q1 2026
Opaleye Management Inc. · Added
Change +143K Date Q1 2026
Opaleye Management Inc. Added· Q1 2026 +143K Q1 2026
BNP Paribas Financial Markets · Added
Change +132K Date Q1 2026
BNP Paribas Financial Markets Added· Q1 2026 +132K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 108

Famous investor activity in Atea Pharmaceuticals, Inc. (AVIR)

Atea Pharmaceuticals, Inc. (AVIR) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Lucidi Bruno · Director 2 operations 0
Owned 0 Trade date Jun 18, 2026 Filed date Jun 23, 2026
Lucidi Bruno Director 2 operations 0 0 Jun 18, 2026 Jun 23, 2026
Lucidi Bruno · Director 2 operations 64K
Owned 38K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Lucidi Bruno Director 2 operations 64K 38K Jun 18, 2026 Jun 23, 2026
Berger Franklin M. · Director 2 operations 0
Owned 0 Trade date Jun 18, 2026 Filed date Jun 23, 2026
Berger Franklin M. Director 2 operations 0 0 Jun 18, 2026 Jun 23, 2026
Berger Franklin M. · Director 2 operations 64K
Owned 38K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Berger Franklin M. Director 2 operations 64K 38K Jun 18, 2026 Jun 23, 2026
Berman Howard · Director 2 operations 64K
Owned 38K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Berman Howard Director 2 operations 64K 38K Jun 18, 2026 Jun 23, 2026
Duncan Barbara Gayle · Director 2 operations 0
Owned 0 Trade date Jun 18, 2026 Filed date Jun 23, 2026
Duncan Barbara Gayle Director 2 operations 0 0 Jun 18, 2026 Jun 23, 2026
Duncan Barbara Gayle · Director 2 operations 64K
Owned 38K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Duncan Barbara Gayle Director 2 operations 64K 38K Jun 18, 2026 Jun 23, 2026
Polsky Bruce · Director 2 operations 0
Owned 0 Trade date Jun 18, 2026 Filed date Jun 23, 2026
Polsky Bruce Director 2 operations 0 0 Jun 18, 2026 Jun 23, 2026
Polsky Bruce · Director 2 operations 64K
Owned 38K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Polsky Bruce Director 2 operations 64K 38K Jun 18, 2026 Jun 23, 2026
Murphy Polly A. · Director 2 operations 0
Owned 0 Trade date Jun 18, 2026 Filed date Jun 23, 2026
Murphy Polly A. Director 2 operations 0 0 Jun 18, 2026 Jun 23, 2026
Murphy Polly A. · Director 2 operations 64K
Owned 38K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Murphy Polly A. Director 2 operations 64K 38K Jun 18, 2026 Jun 23, 2026
Adams Jerome M. · Director 2 operations 0
Owned 0 Trade date Jun 18, 2026 Filed date Jun 23, 2026
Adams Jerome M. Director 2 operations 0 0 Jun 18, 2026 Jun 23, 2026
Adams Jerome M. · Director 2 operations 64K
Owned 38K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Adams Jerome M. Director 2 operations 64K 38K Jun 18, 2026 Jun 23, 2026
Kirsch Arthur S. · Director 2 operations 64K
Owned 38K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Kirsch Arthur S. Director 2 operations 64K 38K Jun 18, 2026 Jun 23, 2026
Corcoran Andrea · Officer 2 operations 120K
Price $1.24 Owned 0 Trade date Mar 11, 2026 Filed date Mar 13, 2026
Corcoran Andrea Officer 2 operations $1.24 120K 0 Mar 11, 2026 Mar 13, 2026
15 of 33
15 of 33 Sign in to continue to older insider transactions.

Atea Pharmaceuticals, Inc. (AVIR) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
FMR LLC 12.0M
% of shares outstanding 15.0% Filing date May 6, 2026
FMR LLC 12.0M 15.0% May 6, 2026
BlackRock Inc. 9.4M
% of shares outstanding 11.3% Filing date Jan 24, 2024
BlackRock Inc. 9.4M 11.3% Jan 24, 2024
Ecor1 Capital, LLC 7.0M
% of shares outstanding 8.4% Filing date Feb 14, 2024
Ecor1 Capital, LLC 7.0M 8.4% Feb 14, 2024
Bml Investment Partners, L.P. 6.8M
% of shares outstanding 8.1% Filing date Dec 16, 2024
Bml Investment Partners, L.P. 6.8M 8.1% Dec 16, 2024
Sommadossi Jean-Pierre 5.9M
% of shares outstanding 7.1% Filing date Feb 13, 2024
Sommadossi Jean-Pierre 5.9M 7.1% Feb 13, 2024
Sommadossi Jean-Pierre 5.9M
% of shares outstanding 6.9% Filing date May 14, 2025
Sommadossi Jean-Pierre 5.9M 6.9% May 14, 2025
Bml Investment Partners, L.P. 5.5M
% of shares outstanding 6.7% Filing date Feb 7, 2024
Bml Investment Partners, L.P. 5.5M 6.7% Feb 7, 2024
FMR LLC 5.4M
% of shares outstanding 6.4% Filing date Feb 9, 2024
FMR LLC 5.4M 6.4% Feb 9, 2024
8 of 16

Atea Pharmaceuticals, Inc. (AVIR) ownership FAQ

Who owns AVIR?

108 reporting institutions disclosed AVIR position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.